In many industries, responsible, sustainable business activity is already an integral part of corporate strategies. There is increasing pressure also on the pharmaceutical industry because suppliers and stakeholders alike face new requirements and legal regulations in the near future. Just some examples are the Corporate Sustainability Reporting Directive, the EU’s Green Deal and the Supply Chain Duty of Care Act. One area that offers real potential for companies to improve their environmental impact today is product packaging.

Most global players on the market have already pledged to reduce their resource consumption, implement greener production technologies and cut packaging waste. Often, their declared goal is climate neutrality.

Both Challenge and Opportunity

Companies can take the first steps by implementing measures such as switching to renewable energies, embracing e-mobility and using smaller secondary packaging tailored to their products. However, the pharmaceutical and life science industry is hampered by strict regulations and complicated approval and qualification procedures for their products. This also applies to product packaging, which makes changing to greener packaging concepts very costly and time consuming. However, with new approval procedures, companies have the opportunity to improve sustainability today without additional expenses. They can choose a recyclable alternative for their primary packaging.

 As a proven partner to the healthcare industry for many years, SÜDPACK MEDICA has a profound understanding of these requirements. The company is one of the most innovative suppliers of high-performance films. At an early stage, its management recognised the complex challenge of combining product protection and sustainability in a single solution. Ever since, the company has been working intensively on developing more material-efficient, recyclable solutions for the pharmaceutical and medical goods industry that meet stakeholder requirements and also its own sustainability goals.